Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Monoclonals expand into neural disorders

Nature Biotechnology volume 24, pages 595–596 (2006)Cite this article

In April, Pfizer bought a Genentech spinoff, Rinat Neuroscience, for close to five hundred million dollars

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. Washington, D.C.

    Brian Vastag

Authors
  1. Brian Vastag
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Biotech jostles with pharma for slice of HIV market

GlaxoSmithKline cancer drug threatens Herceptin market

Web links

Pfizer

Rinat Neuroscience

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vastag, B. Monoclonals expand into neural disorders. Nat Biotechnol 24, 595–596 (2006). https://doi.org/10.1038/nbt0606-595

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0606-595

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing